Rebalix
Logo SPDRSPDR · sheet of 4 September 2026
ETF sheet · official issuer and register data

State Street® SPDR® Bloomberg Emerging Markets Local Bond UCITS ETF (Acc)

EMLA · IE00BFWFPY67 · USD · domicile Ireland
Bonds · Government · Broad (all maturities) · Emerging marketsSFDR art. 6 (inferred)
Index tracked: Bloomberg Emerging Markets Local Currency Liquid Government Bond Index
TER
0.55%+ trans. 0.00%
Fund size
1.5 bn EUR
Tracking difference
−0.90%3-year avg
🇮🇹 tax rate
13.16%white list 95.14%
Replication
Physical (sampled)
Income
Accumulating
Duration
6.23 yrsmedium (3–7 years)
Launch 19 Jul 2018 · costs from the KID as of 2 Sept 2026 · 626 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
Investment objective The objective of the Fund is to track the performance of the debt markets in emerging market countries for liquid local currency securities. The Fund seeks to track the performance of the Bloomberg Emerging Markets Local Currency Liquid Government Bond Index (the "Index") as closely as possible. The Fund is an index tracking fund (also known as a passively managed fund). Investment policies The Fund invests primarily in securities included in the Index. These include bonds issued by governments in emerging market countries. These…

Performance since series start (in euro) — base 100

20 Jul 20183 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
201920212023202512096120
High 120 (19 Feb 2020) · low 96 (5 Sept 2018) · last 120. Past performance is not indicative of future results.

Returns in euro

1 year+5.2%
3 years+12.0%
5 years+9.1%
10 yearsseries too young
Since series start+19.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)6.27%6.22%6.87%
Max drawdown−6.22%−7.61%−23.41%
Sharpe0.400.50-0.14
Sortino0.620.75-0.19
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EMLA · IE00BFWFPY671
RebalixEMLA · IE00BFWFPY67 · sheet of 4 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+15.70%+16.65%−0.95%
2024−3.05%−2.22%−0.84%
2023+10.44%+11.34%−0.90%
2022−10.72%−10.24%−0.49%
2021−8.42%−7.80%−0.62%

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 82.2%
Rating breakdown (% of fund)
Aaa0.7%Aa13.2%A28.8%Baa39.4%Below Baa16.7%Not rated1.2%
Maturity breakdown (% of fund)
< 1 year1.2%1–3 years21.6%3–5 years19.5%5–7 years12.3%7–10 years17.6%10–20 years14.8%> 20 years13.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
EMLA · Borsa Italiana (ETFplus)
SPFA · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 8 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ssga.com/library-content/kids?isin=IE00BFWFPY67&documentType=kid&c
Factsheet · www.ssga.com/library-content/products/factsheets/etfs/emea/factsheet-e
Prospectus · www.ssga.com/library-content/products/fund-docs/etfs/emea/1-IE-EN-FP-I
The live sheet, always up to date
rebalix.com/en/etf/IE00BFWFPY67
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EMLA · IE00BFWFPY672